Skip to main content
David Delurgio, MD, Cardiology, Atlanta, GA, Emory University Hospital

DavidBDelurgioMDFACC, FHRS

Cardiology Atlanta, GA

Cardiac Electrophysiology

Professor of Medicine, Emory University, Director of Electrophysiology, Emory St. Joseph's Hospital

Dr. Delurgio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Delurgio's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1993 - 1995
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1993
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - Present
  • GA State Medical License
    GA State Medical License 1995 - 2025
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • American Board of Internal Medicine Cardiac Electrophysiology
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • Atlanta Magazine: Top Doctors Castle Connolly, 2009-2017
  • America's Top Doctors Castle Connolly, 2010-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Catheter Ablation with Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation  
    Akash Makkar, Rahul N Doshi, David Delurgio, Charles A Athill, Kenneth A Ellenbogen, Andrea Natale, Jayanthi Koneru, Irakli Giorgberidze, Neal S Kleiman, JAMA

Authored Content

  • Hybrid Convergent Ablation for the Treatment of Persistent and Long-Standing Persistent AF: Results of CONVERGE TrialMarch 2021

Press Mentions

  • YOUR HEALTH: Slowing down the Heart in a New Way
    YOUR HEALTH: Slowing down the Heart in a New WaySeptember 28th, 2018
  • New Procedure Helps Patients Control Atrial Fibrillation
    New Procedure Helps Patients Control Atrial FibrillationSeptember 21st, 2018
  • AtriCure Names National Principal Investigator for the CONVERGE IDE Clinical Trial
    AtriCure Names National Principal Investigator for the CONVERGE IDE Clinical TrialMarch 14th, 2017

Professional Memberships

Hospital Affiliations